Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-16

FDA Approved: FINGOLIMOD — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for Fingolimod submitted by Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

SUPPL AP for FINGOLIMOD (FINGOLIMOD)